Intravitreal bevacizumab for pseudophakic cystoid macular edema.
Gianluca
G
Carifi
D020533:Angiogenesis Inhibitors / Q000008:administration & dosage*; D000911:Antibodies, Monoclonal / Q000008:administration & dosage*; D003930:Diabetic Retinopathy / Q000517:prevention & control*; D005260:Female; D006801:Humans; D008269:Macular Edema / Q000517:prevention & control*; D008297:Male; D018918:Phacoemulsification; D011183:Postoperative Complications / Q000517:prevention & control*
D020533:Angiogenesis Inhibitors; D000911:Antibodies, Monoclonal